Your browser doesn't support javascript.
loading
OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis via regulating the arachidonic acid metabolism.
Wen, Jie; Aili, Abudureyimujiang; Yan, Yao Xue; Lai, YuLin; Niu, Shaoqing; He, Shasha; Zhang, Xiaokai; Zhang, Guixiong; Li, Jiaping.
Affiliation
  • Wen J; Department of Interventional Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China and Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing, China.
  • Aili A; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing, China.
  • Yan YX; Department of Dermatology, Peking University People's Hospital, Beijing, China.
  • Lai Y; Deparment of Radiotherapy, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Niu S; Deparment of Radiotherapy, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • He S; Deparment of Radiotherapy, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Zhang X; Department of Interventional Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Zhang G; Department of Interventional Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Li J; Department of Interventional Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Front Oncol ; 12: 977348, 2022.
Article in En | MEDLINE | ID: mdl-36132142
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Oncol Year: 2022 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Oncol Year: 2022 Type: Article Affiliation country: China